Drug kinetics release from Eudragit - Tenofovir@SiOC tablets

被引:23
|
作者
Tamayo, A. [1 ]
Mazo, M. A. [1 ]
Veiga, M. D. [2 ]
Ruiz-Caro, R. [2 ]
Notario-Perez, F. [2 ]
Rubio, J. [1 ]
机构
[1] CSIC, Ceram & Glass Inst, Madrid, Spain
[2] Univ Complutense Madrid, Fac Pharm, Dept Pharmaceut Technol, Madrid, Spain
来源
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2017年 / 75卷
关键词
Silicon oxycarbide; Tenofovir release; Porous particles; Kinetics; Functionalization; MESOPOROUS SILICA MATERIALS; IN-VITRO; ADSORPTION; IBUPROFEN; NANOPARTICLES; MOLSIDOMINE; CARRIERS; SURFACE; EQUILIBRIUM; MECHANISM;
D O I
10.1016/j.msec.2017.03.016
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
A novel drug release system has been obtained in form of tablets from Eudragit RS and tenofovir loaded on porous silicon, oxycarbide glasses (SiOC). Active carbon (AC) and mesoporous silica (MCM-41) have also been used for comparative purposes. The porous silicon oxycarbide presents a bimodal mesopore size distribution that is maintained after functionalization with amino groups. We have studied the adsorption kinetics and adsorption equilibrium when the materials are loaded with tenofovir and, in all cases, pseudo-second order kinetics and Langmuir isotherm have been revealed as the most representative models describing the kinetic and thermodynamic parameters. Besides, the tenofovir adsorption on these materials turns out to be a favorable process. In vitro release of tenofovir has been studied in simulated vaginal medium by applying different release models. Continuous tenofovir release for >20 days has been obtained for the SiOC material functionalized with amine groups. We concluded that the drug release occurs in two steps that involve a drug diffusion step through the material pores and diffusion through the swollen polymer. The interactions between the tenofovir drug and de amine groups of the functionalized silicon oxycarbide also play an important role in the release process (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:1097 / 1105
页数:9
相关论文
共 50 条
  • [31] CONTROLLED RELEASE SALBUTAMOL SULFATE MOLDED TABLETS USING EUDRAGIT RETARD
    HASHEM, F
    ELDIEN, EEZ
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (03) : 541 - 549
  • [32] Controlled release matrix tablets of zidovudine:: Effect of formulation variables on the in vitro drug release kinetics
    Ravi, Punna Rao
    Kotreka, Udaya Kanth
    Saha, Ranendra Narayan
    AAPS PHARMSCITECH, 2008, 9 (01) : 302 - 313
  • [33] Controlled Release Matrix Tablets of Zidovudine: Effect of Formulation Variables on the In Vitro Drug Release Kinetics
    Punna Rao Ravi
    Udaya Kanth Kotreka
    Ranendra Narayan Saha
    AAPS PharmSciTech, 2008, 9 : 302 - 313
  • [34] Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir
    Cazorla-Luna, Raul
    Notario-Perez, Fernando
    Martin-Illana, Araceli
    Ruiz-Caro, Roberto
    Tamayo, Aitana
    Rubio, Juan
    Dolores Veiga, Maria
    PHARMACEUTICS, 2019, 11 (01):
  • [35] The Effect of Polymers Composition on the Release of Drug From Controlled Release Tablets
    Alhmoud, Hassan A.
    Alhmoud, Dieaa H.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2019, 38 (02): : 323 - 328
  • [36] TESTING OF DRUG RELEASE FROM BIOADHESIVE VAGINAL TABLETS
    GURSOY, A
    BAYHAN, A
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1992, 18 (02) : 203 - 221
  • [37] TESTING OF DRUG RELEASE FROM BIOADHESIVE VAGINAL TABLETS
    GURSOY, A
    BAYHAN, A
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (18) : 2457 - 2475
  • [38] Predicting drug release from HPMC/lactose tablets
    Siepmann, J.
    Karrout, Y.
    Gehrke, M.
    Penz, F. K.
    Siepmann, F.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 441 (1-2) : 826 - 834
  • [39] Effect of pH on drug release from polysaccharide tablets
    Park, HY
    Choi, CR
    Kim, JH
    Kim, WS
    DRUG DELIVERY, 1998, 5 (01) : 13 - 18
  • [40] Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone
    Hardy, Ian J.
    Windberg-Baarup, Anne
    Neri, Claudia
    Byway, Paul V.
    Booth, Steven W.
    Fitzpatrick, Shaun
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 337 (1-2) : 246 - 253